Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Flow Cytometry

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Successful percutaneous treatment of a large arteriovenous fistula between the right coronary artery to main pulmonary artery.

Coronary artery disease·2020

Same author

An unusual complication during alcohol septal ablation: severe left anterior descending artery vasospasm causing cardiac arrest: a case report and review of the literature.

European heart journal. Case reports·2019

Same author

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2017

Same author

The relationship between neutrophil-lymphocyte ratio and acute aortic dissection.

Perfusion·2017

Same author

Neutrophil-lymphocyte ratio and right ventricular dysfunction.

Cardiology journal·2016

Same author

Gamma-glutamyl transferase and pulmonary embolism.

Sao Paulo medical journal = Revista paulista de medicina·2016

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters.

Turgay Celik¹, Sevket Balta¹, Dimitri P Mikhailidis²

¹1 Department of Cardiology, School of Medicine, Gulhane Military Medical Academy, Ankara, Turkey.

|July 16, 2016

Summary

Complete blood count parameters can predict the no-reflow phenomenon in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). These hematological markers offer insights into reperfusion success.

Keywords:

complete blood count neutrophil–lymphocyte ratio no-reflow phenomenon platetecrit primary percutaneous coronary intervention red cell distrubiton width

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Related Experiment Videos

Last Updated: Jul 17, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Area of Science:

Cardiology
Hematology
Clinical Diagnostics

Background:

The no-reflow (NR) phenomenon is a critical complication in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI).
Complete blood count (CBC) parameters are routinely measured and have shown potential in predicting various clinical outcomes.

Purpose of the Study:

To review the utility of admission CBC parameters in predicting the no-reflow phenomenon.
To assess the role of hematological markers in patients with STEMI undergoing pPCI.

Main Methods:

Review of existing literature on the association between CBC parameters and NR in STEMI patients.
Analysis of automated cell counter-derived markers such as red blood cell distribution width (RDW) and plateletcrit.
Evaluation of ratios like neutrophil-lymphocyte ratio and RDW-platelet ratio.

Main Results:

Certain CBC parameters, including RDW and platelet indices, have emerged as independent predictors of impaired angiographic reperfusion.
Hematological markers may stratify risk for adverse outcomes in STEMI patients post-pPCI.
The predictive value of admission CBC for NR requires further investigation.

Conclusions:

Admission CBC parameters hold promise as accessible biomarkers for predicting the no-reflow phenomenon in STEMI patients.
Further research is warranted to establish specific CBC thresholds for NR prediction.
Integrating CBC analysis into routine practice could aid in risk stratification and management of STEMI patients.